Deere (DE) Suffers a Larger Drop Than the General Market: Key Insights

Deere fell 1.4% to $641.53 in the latest session and is down 5.1% over the past month, underperforming the S&P 500, which gained 2.44% over that period. Ahead of its November 25, 2026 earnings release, quarterly consensus calls for EPS of $4.07 (+3.56% year over year) and revenue of $10.3 billion (-2.59%); the full-year forecast is $18.11 EPS and $41.35 billion revenue. Consensus EPS estimates edged down 0.05% over the past month, and Deere carries a Zacks Rank of #3 (Hold) and a 35.93 forward P/E versus the industry's 19.36.

Analysis

The underperformance is a weak signal by itself: the reported monthly EPS-consensus decline is negligible, so this does not yet establish a broad earnings reset. The more consequential risk is asymmetric valuation: if Deere’s earnings outlook softens, a premium multiple can compress before reported results show a clear deterioration. But the quoted forward P/E may also overstate expensiveness if current estimates sit near a cyclical earnings trough; do not treat the industry multiple comparison as proof of overvaluation.

Over the next few weeks, estimate breadth and management commentary matter more than the daily price move. For the November 25 release, verify order trends, dealer inventory, pricing, and demand by equipment segment; the article does not establish those conditions. Over 6–18 months, farm income, crop prices, and financing costs could affect replacement cycles, while weak new-equipment demand may support used-equipment supply and pressure dealer economics. That would also intensify competition from CNH Industrial and AGCO, but there is no evidence here of share shifts.

Contrarian read: the market may be extrapolating a cyclical slowdown from a small move, while the larger risk is that consensus estimates have not yet caught up. A sustained recovery in estimates and orders would challenge the bear case; successive estimate cuts, weaker order commentary, or rising dealer inventories would strengthen it.

Key Decisions for Investors

• Do not trade the one-day underperformance in isolation. Keep DE neutral to underweight pending evidence from estimate revisions and order/dealer data.
• Watch for confirmation ahead of November 25: broadened EPS cuts or weaker order and inventory commentary would support a tactical short or reduced exposure; avoid initiating solely on the current marginal estimate change.
• If positioning a bearish view, define risk around the earnings event rather than using an unhedged short by default; option pricing and liquidity are not provided, so no options structure is recommended.
• Falsification: upward estimate revisions accompanied by improving orders and stable dealer inventories would undermine the downside thesis and make the valuation premium more defensible.